Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MPL anticorps (AA 26-175)

L’anticorps Souris Monoclonal anti-MPL a été validé pour FACS et ELISA. Il convient pour détecter MPL dans des échantillons de Humain.
N° du produit ABIN5611182

Aperçu rapide pour MPL anticorps (AA 26-175) (ABIN5611182)

Antigène

Voir toutes MPL Anticorps
MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))

Reactivité

  • 60
  • 27
  • 23
  • 1
  • 1
Humain

Hôte

  • 54
  • 8
  • 1
Souris

Clonalité

  • 54
  • 9
Monoclonal

Conjugué

  • 25
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp MPL est non-conjugé

Application

  • 40
  • 37
  • 15
  • 13
  • 13
  • 8
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), ELISA

Clone

1D6B7
  • Épitope

    • 32
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 26-175

    Fonction

    CD110 Antibody

    Purification

    Purified antibody

    Immunogène

    Purified recombinant fragment of human CD110 (AA: 26-175) expressed in E. Coli.

    Isotype

    IgG2a
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified antibody in PBS with 0.05 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Antigène

    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))

    Autre désignation

    CD110

    Sujet

    In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.

    Poids moléculaire

    71.2 kDa

    ID gène

    4352

    UniProt

    P40238

    Pathways

    Signalistation JAK/STAT
Vous êtes ici:
Chat with us!